Description
Book SynopsisThis comprehensive guide offers a state-of-the-art overview of basic and clinical aspects of atopic dermatitis (AD).
The name "atopic dermatitis" was first used in 1933, and Drs. Lewis Webb Hill and Marion B. Sulzberger presented their report "Evolution of atopic dermatitis" in 1935. Their observations accurately forecasted the contemporary issues in the management of the condition, such as the conclusions that should be drawn from our understanding of the pathogenesis of AD, and the use of steroids as the main treatment. Several aggravating factors have recently been identified, and these also need to be addressed.
In this context, the expert contributors to this book describe and discuss the evolution of atopic dermatology from Sulzberger’s era to the present day, including clinical manifestations, etiopathology and treatment. In addition, it explores skin care intervention, the role of microbiom and GWAS studies, and presents unique, previously unpublished cohort studies.
It provides insights into the dynamic changes in AD since Sulzberger introduced topical steroids for its treatment. It is a valuable resource for dermatologists, medical practitioners and researchers who are interested in atopic dermatology.
Table of ContentsPart 1. Introduction
1.- History and definition
Part 2. Epidemiology
2.- Epidemiology of Childhood AD in Japan
3.- Epidemiology of Childhood AD in Asican countries
4.- Retrospective cohort study in Adlescent AD
Part 3. Genetics
5.- GWAS study in Japanese AD
Part 4. Etiopathology
6.- Etiopathology of AD from Japanese studies
7.- Non-immunological aspect:Barrier
8.- Immunological aspect: Th2/Mast cell
9.- Immunological aspect: DC/ILC
10.- Cytokine network
11.- Itch and psychiatric aspect
12.- Sweat
13.- Microbiom
14.- Stress
Part 5. Classification
15.- Classification (Intrinsic & Extrinsic type)
Part 6. Clinical manifestations
16.- Infantile and childhood AD
17.- Adult type AD
18.- Senile AD
19.- Differential Diagnosis
Part 7. Diagnosis
20.- Diagnosis and Japanese guideline
Part 8. Management
21.- Drug therpay: Ointment
22.- Drug therpay: Systemic
23.- Skin care and intervention
24.- Approach for gaggravating factors
25.- WPAI
26.- New and future therapies
Part 9. Complications
27.- Pollenopsis
28.- Food Allergy
29.- Asthma
Part 10. Clinical questions
30.- Clinical questions.
